PDA Annual Meeting
Modern Sterile Product Manufacture – Exploring Best Practices and Seeking New Approaches
April 15 – 17, 2013 | The Peabody Orlando | Orlando, Florida
Podcast
Keynote Speakers
Keynote Speaker, David Cutler, PhD will speak on the “Affordable Healthcare Act and the Impact on Industry”
Professor Cutler served on the Council of Economic Advisers and the National Economic Council during the Clinton Administration, and has advised the Presidential campaigns of Bill Bradley, John Kerry and Barack Obama as well as being Senior Health Care Advisor for the Obama Presidential Campaign. Read more.
Closing Speaker, John S. Yu, MD will speak on “The Future of Personalized Medicine”
John S. Yu, MD is the Director of Surgical Neuro-oncology, Medical Director of the Brain Tumor Center, and the Neurosurgical Director of the Gamma Knife Program at Cedars-Sinai Medical Center. An internationally renowned neurosurgeon, Dr. Yu's clinical focus is on the treatment of malignant and benign brain and spinal tumors. Read more.
Program Highlights
![]() Download Brochure Request Mailed Copy |
The 2013 PDA Annual Meeting Program Planning Committee, made up of your industry colleagues, recognizes the challenges the industry faces and has designed a conference which will help attendees better appreciate and meet these challenges. We encourage you to attend the meeting and participate in as many of the sessions and events as possible:
|
Overview
Add Event Date to your Calendar
PDA Annual Meetings have become the most widely attended and essential conferences in the pharmaceutical and biopharmaceutical industry for those interested in increasing job knowledge, performance and effectiveness. The 2013 PDA Annual Meeting will continue this trend by offering formal sessions and informal networking opportunities focused on key areas of interest in sterile product manufacturing, biological technologies, and improved process control, as well as a forum to contribute to and influence the advancement of science and regulation. Please join us, your colleagues, and regulators at this very important and not be missed conference.











